                                                 7
        Abstract
        The     present     invention    discloses    drug     synthesis    intermediates
   p-carboxybenzenesulfonic amide synthesis method, comprises the following steps:.
 5 2-methyl-4-hydroxy-3,6-dimethylol toluene, 2,4-pentanedione solution were added to
   the reaction vessel, controlled the stirring speed, increase the solution temperature,
   added the gadolinium oxide in batches; washed with sodium sulfate solution for
   several times, washed with 2-methyl-2,4-pentanediol solution for several times,
   washed with 3-methylfuran solution for several times, adjusted the pH with the oxalic
10 acid solution, recrystallized in the 3-methyl-2-butanone solution, dehydrated with
   dehydration, got the finished product of p-carboxybenzenesulfonic amide.

                                                   1
        Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis
   method
        FIELD OF THE INVENTION
 5      The present invention relates to a method for preparing a pharmaceutical
   intermediate which belongs to the field of organic synthesis, more particularly, relates
   to drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis method.
        GENERAL BACKGROUND
10      P-carboxybenzenesulfonic     amide is mainly used as an organic synthesis
   intermediate and for pharmaceutical synthesis. However, most of the existing synthetic
   methods are using the method that p-toluenesulfonamide reacts with potassium
   permanganate. This method of production requires potassium permanganate as
   reactant, due to the toxicity of potassium permanganate, and it's corrosive, irritating
15 properties cause human burns, the reactant attribute to high-risk chemicals, and the
   synthesis is complicated and the final yield is not very high. Therefore, it is necessary to
   propose a new synthetic method.
        SUMMARY
20      Based on the technical problems of the background technology, the purpose of the
   present invention is to provide drug synthesis intermediates p-carboxybenzenesulfonic
   amide synthesis method, comprises the following steps:
        A: 2-methyl-4-hydroxy-3,6-dimethylol toluene, 2,4-pentanedione solution were
   added to the reaction vessel, controlled the stirring speed at 150-180 rpm, increase the
25 solution temperature to 40-50 'C, added the gadolinium oxide in batches;
        B: increased the temperature of the solution to 70-780 C, reacted for 90-110 min,
   reduced the temperature of the solution to 10-16 C, washed with sodium sulfate
   solution for several times, washed with 2-methyl-2,4-pentanediol solution for several
   times, washed with 3-methylfuran solution for several times, adjusted the pH to 3-3.5
30 with the oxalic acid solution, recrystallized in the 3-methyl-2-butanone solution,

                                                     2
     dehydrated with dehydration, got the finished product of p-carboxybenzenesulfonic
     amide.
           Preferably, the 2,4-pentanedione solution has a mass fraction of 60-70%.
           Preferably, the mass fraction of the sodium sulfate solution is 3540%.
   5       Preferably, the 2-methyl-2,4-pentanediol solution has a mass fraction of 75-80%.
           Preferably, the 3-methylfiran solution has a mass fraction of 80-86%.
4
           Preferably, the mass fraction of oxalic acid solution is 30-35%.
           Preferably, the mass fraction of 3-methyl-2-butanone solution is 85-92%.
           Preferably, the dehydrating agent is any one of anhydrous calcium sulfate and
4 10 anhydrous calcium chloride.
           Throughout the reaction process can be the following reaction formula:
                                    +   CH0   2  + Gd2 03        ,
            HO                 OH
                      CH2OH
           Compared with the synthetic method disclosed in the background art, the
     invention provides drug synthesis intermediates p-carboxybenzenesulfonic amide
  [5 synthesis method, it is unnecessary to use potassium permanganate as reactant,
     avoiding the corrosiveness and irritation of the reactants and reduce the high-risk of
     chemicals, reducing intermediate links reaction, decreasing the reaction time and
     improving the reaction yield, at the same time, the present invention provides a new
     synthetic route which has laid a good foundation for hrther enhancing the yield of the
  20 reaction.
           DESCRIPTION OF THE DRAWINGS
           Figure    1 is the       "CNMR       analysis   spectrum     of finished  product
     p-carboxybenzenesulfonic amide.
  25       Figure 2 is the        atomic position marker map of finished product
     p-carboxybenzencsulfonic amide.

                                                  3
         DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
         The following examples with reference to specific embodiments of the present
   invention are further illustrated:
 5       Embodiment 1
         Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis method,
   comprises the following steps:
         A: 2mol 2-methyl-4-hydroxy-3,6-dimethylol toluene, 3mol 2,4-pentanedione
   solution with a mass fraction of 60% were added to the reaction vessel, controlled the
10 stirring speed at 150 rpm, increase the solution temperature to 40 'C, added 2 mol
   gadolinium oxide in 3 times;
         B: increased the temperature of the solution to 70'C, reacted for 90 min, reduced
   the temperature of the solution to 100 C, washed with sodium sulfate solution with a
   mass fraction of 35% for 3 times, washed with 2-methyl-2,4-pentanediol solution with
15 a mass fraction of   7 5 % for 5 times, washed with 3-methylfuran solution with a mass
   fraction of 80%for 6 times, adjusted the pH to 3 with the oxalic acid solution with a
   mass fraction of 30%, recrystallized in the 3-methyl-2-butanone solution with a mass
   fraction of 85%, dehydrated with anhydrous calcium sulfate dehydration, got the
   finished product of p-carboxybenzenesulfonic amide 357.78g, yield of 89%.
20
         Embodiment 2
         Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis method,
   comprises the following steps:
         A: 2mol 2-methyl-4-hydroxy-3,6-dimethylol toluene, 3.5mol 2,4-pentanedione
25 solution with a mass fraction of 60% were added to the reaction vessel, controlled the
   stirring speed at 160 rpm, increase the solution temperature to 45 'C, added 2.5 mol
   gadolinium oxide in 4 times;
         B: increased the temperature of the solution to 73 C, reacted for 100 min, reduced
   the temperature of the solution to 13 C, washed with sodium sulfate solution with a
30 mass fraction of 37% for 4 times, washed with 2-methyl-2,4-pentanediol solution with

                                                 4
   a mass fraction of 77% for 6 times, washed with 3-methylfuran solution with a mass
   fraction of 83% for 7 times, adjusted the pH to 3.2 with the oxalic acid solution with a
   mass fraction of 32%, recrystallized in the 3-methyl-2-butanone solution with a mass
   fraction of 87%, dehydrated with anhydrous calcium chloride dehydration, got the
 5 finished product of p-carboxybenzenesulfonic amide 369.84g, yield of 92%.
          Embodiment 3
          Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis method,
   comprises the following steps:
10        A: 2mol 2-methyl-4-hydroxy-3,6-dimethylol toluene, 4mol 2,4-pentanedione
   solution with a mass fraction of 70% were added to the reaction vessel, controlled the
   stirring speed at 180 rpm, increase the solution temperature to 50 'C, added 3 mol
   gadolinium oxide in 6 times;
          B:  increased the temperature of the solution to 78 C, reacted for 110 min,
15 reduced the temperature of the solution to 16'C, washed with sodium sulfate solution
   with a mass fraction of 40% for 5 times, washed with 2-methyl-2,4-pentanediol
   solution with a mass fraction of 80% for 7 times, washed with 3-methylfuran solution
   with a mass fraction of 86%for 86 times, adjusted the pH to 3.5 with the oxalic acid
   solution with a mass fraction of 35%, recrystallized in the 3-methyl-2-butanone
20 solution with a mass fraction of 92%, dehydrated with anhydrous calcium sulfate
   dehydration, got the finished product of p-carboxybenzenesulfonic amide 377.86g,
   yield of 94%.
          Nuclear magnetic analysis of finished product p-carboxybenzenesulfonic amide,
   the  1
          3CNMR   analysis spectrum is shown in figure 1, the atomic position marker map
25 of the p-carboxybenzenesulfonic amide is shown in figure 2, the analysis of data is
   shown in Table 1:
30

                                                5
                                     Table 1 Analysis data
                      Chemical          Peak area            Atomic
                         shift         integration           number
                        166.20             200                  1
                        147.65             249                  2
                        133.60              172                 3
                        129.81             974                  4
                        125.83             1000                 5
       The embodiments of the present invention are merely preferred embodiments of
  the present invention, but the range of the present invention is not limited this, and
  any person who is familiar with those skilled in the arts, within the technical range of
5 the present invention. It is intended that the technical solution and its inventive
  concept be replaced or modified equivalently with reference to the range of the
  invention.

                                                  6
         Claims
         1. Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis
   method, comprises the following steps:
         A: 2-methyl-4-hydroxy-3,6-dimethylol toluene, 2,4-pentanedione solution were
 5 added to the reaction vessel, controlled the stirring speed at 150-180 rpm, increase the
   solution temperature to 40-50 'C, added the gadolinium oxide in batches;
         B: increased the temperature of the solution to 70-780 C, reacted for 90-110 min,
   reduced the temperature of the solution to 10-16'C, washed with sodium sulfate
   solution for several times, washed with 2-methyl-2,4-pentanediol solution for several
10 times, washed with 3-methylfuran solution for several times, adjusted the pH to 3-3.5
   with the oxalic acid solution, recrystallized in the 3-methyl-2-butanone solution,
   dehydrated with dehydration, got the finished product of p-carboxybenzenesulfonic
   amide.
15       2. Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis
   method according to claim 1 wherein the 2,4-pentanedione solution has a mass
   fraction of 60-70%.
         3. Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis
20 method according to claim 1 wherein the mass fraction of the sodium sulfate solution
   is 35-40%.
         4. Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis
   method according to claim 1 wherein the 2-methyl-2,4-pentanediol solution has a
25 mass fraction of 75-80%.

<removed-apn> <removed-date>
